4281.0 Making HIV Policy Change Real: The Case of Non-Prescription Pharmacy Sales to Prevent HIV among Injection Drug Users in California: 2005-2007

Tuesday, October 28, 2008: 2:30 PM
Increasing access to sterile syringes for injection drug users (IDUs) has been politically controversial in the United States. Nonetheless, all but 14 states now have syringe exchange programs (SEPs) and nearly all permit over-the-counter (OTC) pharmacy sales of syringes without a physician’s prescription. One of the last states to permit OTC pharmacy sales is California. In 2005, statewide policymakers permitted pharmacy sales of up to 10 syringes to adults without a medical prescription if local county governments formally approved of it and the local health department registered pharmacies. A recent analysis of SEP access in California indicated that this approach type of approach (requiring local government approval) resulted in more SEPs in the state but no increase in SEPs high-need counties (Bluthenthal et al. AJPH 2008). In this panel, presentations will provide a comprehensive description of the implementation and outcomes of this HIV policy change including documenting political dynamics, pharmacy participation, public health department successes and challenges, and use of pharmacies by IDUs.
Session Objectives: Participants will be able to: 1. Describe contemporary policies associated with public health's role in syringe exchange programs. 2. Describe the outcomes of recent policy change in California with regard to HIV among injection drug users. 3. List best practice standards for the development and implementation of effective policies related to syringe exchange.

2:30 PM
2:42 PM
Three Years into Legalization of Over-the-Counter (OTC) Syringe Sales in California (SB1159): Where are we now?
Richard S. Garfein, PhD, MPH, Thomas Stopka, MHS, Patricia B. Pavlinac, BA, Karen Haye, Elise D. Riley, PhD and Ricky N. Bluthenthal, PhD
2:54 PM
Participation and practices in non-prescription syringes sales (NPSS) by pharmacies in Los Angeles and San Francisco, 2007
Richard S. Garfein, PhD, MPH, Erin Cooper, Thomas Stopka, MHS, Elise D. Riley, PhD and Ricky N. Bluthenthal, PhD
3:06 PM
Syringe sources utilized by IDUs in California pre- and post- implementation of a pharmacy-based syringe sales initiative
Thomas J. Stopka, MHS, Atsuko Nonoyama, PhD, Janie F. Shelton, MPH, Juan Ruiz, MD, DrPH, Richard S. Garfein, PhD, MPH, Elise D. Riley, PhD and Ricky N. Bluthenthal, PhD
3:18 PM
Pharmacies augment syringe access to San Francisco's IDUs two years after SB1159
Elise D. Riley, PhD, Alex Kral, PhD, Richard S. Garfein, PhD, MPH, Thomas Stopka, MHS, Lynn D. Wenger, MPH, MSW and Ricky N. Bluthenthal, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: HIV/AIDS
Endorsed by: Socialist Caucus

CE Credits: CME, Health Education (CHES), Nursing

See more of: HIV/AIDS